Podcast

Thomas Seck, MD, on Expanding Empagliflozin Use for Heart Failure

04/04/2018

Dr Thomas Seck, who is the vice president of Clinical Development and Medical Affairs at Boehringer Ingelheim Pharmaceuticals, discusses the EMPERIAL trials, which aim to expand the use of empagliflozin for heart failure.

For more information about the EMPERIAL trials, read the press release here.

For more content related to heart failure, visit HeartFailure360.

Related Content

Public Health
Public Health
Patrick Ayscue, PhD, on Whole Genome Sequencing and COVID-19
06/04/2021
In this podcast, Patrick Ayscue, PhD, answers our questions about the role that whole genome sequencing has had on the COVID-19 pandemic and how this laboratory procedure can be used against variant...
06/04/2021
Inflammatory Bowel Disease
Inflammatory Bowel Disease
Vivian Huang, MSc, MD, on Optimizing the Management of IBD in Pregnancy
05/05/2020
She speaks about her recent systematic review and meta-analysis that aimed to determine the risk of adverse maternal, placental, and obstetric outcomes in women with inflammatory bowel disease.
05/05/2020
Nutrition
Nutrition
Lawrence Appel, MD, on Report: What's Good for the Heart Is Good for the Brain
02/08/2018
Lawrence Appel, MD, from John's Hopkins University, answers our questions about a new report about the impact of diet on brain health among older adults.
02/08/2018
Podcasts
Podcasts
Sonia A. Talwar, MD, on Nail Discoloration: The Many Etiologies
08/03/2018
<p>The author of the April PhotoQuiz, Dr Sonia A. Talwar, talks about her case report as well as other nail discoloration conditions.</p>
08/03/2018
Asthma
Asthma
The Effects of the Environment on Respiratory Health
08/06/2022
In this podcast, Payel Gupta, MD, answers our questions about how the indoor and outdoor environment affects respiratory health, including the impact of climate change on allergies and asthma. 
08/06/2022